Status:

TERMINATED

IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Bacterial Meningitis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Bacterial meningitis is a severe infection of the envelope which surrounds the brain. It is sometimes responsible for a cerebral oedema mattering with a loss of consciousness (coma). The usual treatme...

Detailed Description

Investigational procedure: This study evaluates the impact of mild induced hypothermia (32-34°C) during 48 hours followed by passive rewarming according to recommendations described in appendix. All ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Subject is 18 years of age or older
  • Clinically suspected community-acquired bacterial meningitis (More than 100 white blood cells in CSF and a glucose CSF/Blood ratio of 1/3 or less, or a CSF protein level above 2,2 g/L.)
  • Presence of micro-organisms on CSF Gram's stain examination
  • Positive soluble antigen or PCR for S. pneumoniae or N. meningitides
  • Positive CSF cultures
  • Score on Glasgow Coma Score \< 8
  • Patient received appropriate antimicrobial therapy (according to recommendations)
  • If present, legally acceptable representative has provided written and dated informed consent to participate in the study.
  • EXCLUSION CRITERIA:
  • Glasgow Coma Score \< 8 for more than 12 hours
  • Patients with HIV positivity: positive cryptococcal antigen in blood or CSF; Cerebral abscess
  • pregnancy
  • Subject has been designated as "not full support", "do not resuscitate" or equivalent status which prohibits the use of life supporting interventions thereby limiting options available
  • Subject admitted for a clinical situation in which induced hypothermia is recommended
  • Purpura fulminancy, defined as septic shock with extensive necrotizing purpura and disseminated intravascular coagulation.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2012

    Estimated Enrollment :

    98 Patients enrolled

    Trial Details

    Trial ID

    NCT00774631

    Start Date

    March 1 2009

    End Date

    July 1 2012

    Last Update

    September 17 2012

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hopital Bichat Claude Bernard

    Paris, France, 75018